| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MELTZER LESLIE | Chief Research and Development | C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM | /s/ David Watson, attorney-in-fact for Leslie Meltzer | 02 Sep 2025 | 0002084030 |
No securities are beneficially owned.